Michele D’Andria

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD

Andrea Zanini, Ernesto Crisafulli, Michele D’Andria et al. · Respiratory Care · 2019 · 97 citations · Full text

Medicine, Physical Medicine, Rehabilitation Medicine +17

Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study

Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi et al. · Journal of Clinical Medicine · 2022 · 58 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype

Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi et al. · Respiratory Medicine · 2021 · 48 citations

Medicine, Molecular Medicine, Pharmacotherapy +13

Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis

Donatello Salvatore, Michele D’Andria · Pediatric Pulmonology · 2002 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +14

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease

Vito Terlizzi, C. Colangelo, Giovanni Marsicovetere et al. · Genes · 2021 · 29 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14